![image1](http://www.globenewswire.com/en/Attachment/LogoDisplay/366387?filename=366387.png&size=2)
Neuronetrix publishes peer-reviewed paper validating the clinical application of ERP biomarkers for use in Alzheimer's disease
November 18, 2015 10:22 ET
|
Neuronetrix
LOUISVILLE, Ky., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Neuronetrix announced today the publication of results from its multi-center clinical trial in a prestigious Alzheimer's journal. The report, "A...
![Neuronetrix logo](/news-release/logo/366388/0/366388.jpg?lastModified=12%2F11%2F2016%2006%3A55%3A12&size=2)
Neuronetrix joins big pharma to sponsor conference on Clinical Trials for Alzheimer's Disease
October 29, 2015 14:03 ET
|
Neuronetrix
LOUISVILLE, Ky., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Neuronetrix announced today that it has joined pharma giants Lilly, Roche, Lundbeck, Janssen, and others to sponsor the 8th Annual Clinical Trials on...